S

Stenocare A/S
CSE:STENO

Watchlist Manager
Stenocare A/S
CSE:STENO
Watchlist
Price: 1.3 DKK
Market Cap: 26m DKK
Have any thoughts about
Stenocare A/S?
Write Note

Stenocare A/S
Free Cash Flow

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Stenocare A/S
Free Cash Flow Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Free Cash Flow CAGR 3Y CAGR 5Y CAGR 10Y
S
Stenocare A/S
CSE:STENO
Free Cash Flow
-kr10.2m
CAGR 3-Years
31%
CAGR 5-Years
-13%
CAGR 10-Years
N/A
Novo Nordisk A/S
CSE:NOVO B
Free Cash Flow
kr67B
CAGR 3-Years
19%
CAGR 5-Years
13%
CAGR 10-Years
10%
H Lundbeck A/S
CSE:HLUN A
Free Cash Flow
kr3.6B
CAGR 3-Years
2%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ALK-Abello A/S
CSE:ALK B
Free Cash Flow
kr288m
CAGR 3-Years
54%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Stenocare A/S
Glance View

Market Cap
23.6m DKK
Industry
Pharmaceuticals

Stenocare A/S engages in the cultivation, manufacture, and distribution of medical cannabis products. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The firm distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

STENO Intrinsic Value
0.45 DKK
Overvaluation 66%
Intrinsic Value
Price
S

See Also

What is Stenocare A/S's Free Cash Flow?
Free Cash Flow
-10.2m DKK

Based on the financial report for Dec 31, 2023, Stenocare A/S's Free Cash Flow amounts to -10.2m DKK.

What is Stenocare A/S's Free Cash Flow growth rate?
Free Cash Flow CAGR 5Y
-13%

Over the last year, the Free Cash Flow growth was 36%. The average annual Free Cash Flow growth rates for Stenocare A/S have been 31% over the past three years , -13% over the past five years .

Back to Top